Med24
Clinical Medicine 14. 10. 2026 • 2 min read • medical-news

Promising E. Coli Vaccine Fizzles in Late-Stage Trial

An investigational vaccine targeting the Escherichia coli pathogens that commonly cause infections didn't show a protective effect in older adults, the phase III E.mbrace trial found. Among over 17,000 participants ages 60 and...

Promising E. Coli Vaccine Fizzles in Late-Stage Trial

The E.mbrace trial, a late-stage clinical trial evaluating an investigational vaccine targeting ExPEC9V, did not demonstrate a protective effect in older adults with a history of UTI. The trial involved over 17,000 participants aged 60 and older. Twenty-four cases of invasive ExPEC9V disease were observed, 11 in the vaccine group and 13 in the placebo group, resulting in a vaccine efficacy rate of 14.6%. Development of the vaccine has been discontinued. The study identified systemic immunity was induced, but the magnitude or quality of the immunity was insufficient to provide clinical protection against invasive ExPEC9V disease.

The trial enrolled medically stable adults with a history of UTI, focusing on those with additional risk factors. Participants received a single intramuscular shot of the ExPEC9V vaccine or a placebo. Despite similar pre-vaccination antibody levels, geometric mean antibody titers rose in the vaccine group at 30 days, but declined over time and overlapped with the placebo group at 366 days. The disappointing clinical efficacy may be due to a lack of response to the specific serotype causing a patient’s infection, inadequate mucosal immunity, or protective urinary tract abnormalities.

Sponsored content

The study found that eight of the nine vaccine serotypes were linked to IED in both groups. Local and systemic adverse events were observed, with pain and tenderness being common. Limitations included the inclusion of only older adults and demographic biases in the participant population. Immunogenicity testing was conducted among a subset of participants.”} p>

Original Scientific Source
medical-news
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement